Verve Therapeutics Inc (VERV)

11:38 AM

Transcript : Verve Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 09 - marketscreener.com

11:38 AM

09:30 AM

Verve Therapeutics (VERV) Just Reclaimed the 200-Day Moving Average - Yahoo Finance

09:30 AM

Jun 05, 2025

Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High? - Yahoo Finance

Jun 05, 2025

Jun 04, 2025

BNP Paribas Financial Markets Purchases Shares of 8,876 Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Jun 04, 2025

Jun 03, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by ProShare Advisors LLC - Defense World

Jun 03, 2025

Jun 02, 2025

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 02, 2025

Jun 02, 2025

Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule - marketscreener.com

Jun 02, 2025

Jun 02, 2025

Verve Therapeutics Grants Equity Awards to New Employees as Part of Inducement Stock Incentive Plan - Nasdaq

Jun 02, 2025

Jun 02, 2025

Latest Employee Stock Grants: Verve Therapeutics Issues 87,000 Shares Worth of Equity Awards - Stock Titan

Jun 02, 2025

Jun 01, 2025

Bank of America Corp DE Reduces Position in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Jun 01, 2025

Jun 01, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by Ameriprise Financial Inc. - Defense World

Jun 01, 2025

May 31, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Purchased by Deutsche Bank AG - Defense World

May 31, 2025

May 30, 2025

Nuveen Asset Management LLC Sells 355,953 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 30, 2025

May 29, 2025

37,984 Shares in Verve Therapeutics, Inc. (NASDAQ:VERV) Acquired by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025

May 29, 2025

Verve Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationVERV - ACCESS Newswire

May 29, 2025

May 28, 2025

Canaccord Genuity Reaffirms Their Buy Rating on Verve Therapeutics (VERV) - The Globe and Mail

May 28, 2025

May 28, 2025

Verve Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 28, 2025

May 28, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely - simplywall.st

May 28, 2025

May 27, 2025

Verve Therapeutics, Inc. (NASDAQ:VERV) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 27, 2025

May 25, 2025

Verve Therapeutics (NASDAQ:VERV) Upgraded at Wall Street Zen - Defense World

May 25, 2025

May 23, 2025

Northern Trust Corp Raises Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 23, 2025

May 22, 2025

Transcript : Verve Therapeutics, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 03 - marketscreener.com

May 22, 2025

May 22, 2025

Analysts Offer Predictions for VERV FY2026 Earnings - Defense World

May 22, 2025

May 21, 2025

3 Top Genomics Stocks to Add to Your Portfolio in 2025 - Yahoo Finance

May 21, 2025

May 20, 2025

Verve Therapeutics Leads The Charge With 2 Other Promising Penny Stocks - simplywall.st

May 20, 2025

May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025

May 19, 2025

News Flash: Analysts Just Made An Incredible Upgrade To Their Verve Therapeutics, Inc. (NASDAQ:VERV) Forecasts - simplywall.st

May 19, 2025

May 19, 2025

Analyst Forecasts For Verve Therapeutics, Inc. (NASDAQ:VERV) Are Surging Higher - Yahoo Finance

May 19, 2025

May 19, 2025

Cantor Fitzgerald Issues Positive Outlook for VERV Earnings - Defense World

May 19, 2025

May 18, 2025

Price T Rowe Associates Inc. MD Lowers Position in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 18, 2025

May 17, 2025

Brokerages Set Verve Therapeutics, Inc. (NASDAQ:VERV) PT at $25.75 - Defense World

May 17, 2025

May 16, 2025

Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA) - The Globe and Mail

May 16, 2025

May 15, 2025

Dimensional Fund Advisors LP Raises Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 15, 2025

May 15, 2025

Verve Therapeutics: Q1 Earnings Snapshot - CT Insider

May 15, 2025

May 15, 2025

Verve Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 15, 2025

May 14, 2025

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results - GlobeNewswire

May 14, 2025

May 14, 2025

Verve Therapeutics (VERV) Beats Q1 EPS Estimates, Reports Signif - GuruFocus

May 14, 2025

May 14, 2025

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 14, 2025

May 14, 2025

Verve Therapeutics (VERV) Exceeds Revenue Estimates and Advances - GuruFocus

May 14, 2025

May 14, 2025

Verve Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025

May 14, 2025

Verve Therapeutics (VERV) Exceeds Revenue Estimates and Advances Clinical Trials | VERV Stock News - GuruFocus

May 14, 2025

May 14, 2025

Verve Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025

May 12, 2025

Verve Therapeutics (VERV) Projected to Post Quarterly Earnings on Wednesday - Defense World

May 12, 2025

May 11, 2025

Stifel Financial Corp Purchases 9,736 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 11, 2025

May 11, 2025

Tower Research Capital LLC TRC Lowers Stock Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

May 11, 2025

May 10, 2025

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street - AOL.com

May 10, 2025

May 08, 2025

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

May 08, 2025